Trends in Cardiovascular Medicine
Volume 17, Issue 8 , Pages 253-258, November 2007

Metalloproteinases and Vulnerable Atherosclerotic Plaques

  • Andrew C. Newby

      Affiliations

    • Corresponding Author InformationAddress correspondence to: Andrew Newby, Bristol Heart Institute, Bristol Royal Infirmary, Bristol BS2 8HW, UK. Tel.: (+44) 1179283583; fax: (+44) 1179283581

University of Bristol, Bristol Heart Institute, Bristol Royal Infirmary, Bristol BS2 8HW

Plaque rupture is the main cause of myocardial infarctions and strokes. Ruptured plaques have thin, highly inflamed, and collagen-poor fibrous caps that contain elevated levels of proteases, including metalloproteinases (MMPs), which might weaken plaque caps and promote rupture. On the other hand, MMPs facilitate migration and proliferation vascular smooth muscle cells, which should promote fibrous cap stability. Given the dual effects of MMPs, therapies should selectively target harmful MMPs or the processes that cause MMP activity to rise to destructive levels.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 This study is supported by grants from the British Heart Foundation and the European Vascular Genomics Network.

PII: S1050-1738(07)00178-8

doi:10.1016/j.tcm.2007.09.001

Trends in Cardiovascular Medicine
Volume 17, Issue 8 , Pages 253-258, November 2007